Open access · CC-BY
via OpenAlex
Senolytics prevent caveolar CaV3 . 2‐RyR axis malfunction in old vascular smooth muscle
Jie Ming Lin, Weiming Guo, Qingtian Luo, Qingping Zhang, Teng Wan, Changyu Jiang, Yuanchun Ye, Haihuan Lin, Gang Fan
Aging Cell · 2023 · ▲ 10 citations
Abstract
Abstract Aging is a major risk factor for cardiovascular diseases. Our previous studies demonstrate that aging impairs the caveolar T‐type CaV3.2‐RyR axis for extracellular Ca2+ influx to trigger Ca2+ sparks in vascular smooth muscle cells (VSMCs). We hypothesize that the administration of senolytics(definition), which can selectively clear senescent cells, could preserve the caveolar CaV3.2‐RyR axis in aging VSMCs. In this study, 10‐month‐old mice were administered the senolytics cocktail consisting of dasatinib (5 mg/kg) and quercetin (50 mg/kg) or vehicle bi‐weekly for 4 months. Using VSMCs from mouse mesenteric arteries, we found that Ca2+ sparks were diminished after caveolae disruption by methyl‐β‐cyclodextrin (10 mM) in cells from D + Q treated but not vehicle‐treated 14‐month‐old mice. D + Q treatment promoted the expression of CaV3.2 in 14‐month‐old mesenteric arteries. Structural analysis using electron tomography and immunofluorescence staining revealed the remodeling of caveolae and co‐localization of CaV3.2‐Cav‐1 in D + Q treatment aged mesenteric arteries. In keeping with theoretical observations, Cav3.2 channel inhibition by Ni2+ (50 μM) suppressed Ca2+ in VSMCs from the D + Q group, with no effect observed in vehicle‐treated arteries. Our study provides evidence that age‐related caveolar CaV3.2‐RyR axis malfunction can be alleviated by pharmaceutical intervention targeting cellular senescence(definition). Our findings support the potential of senolytics for ameliorating age‐associated cardiovascular disease.
◌ CITATION ONLY
Full text is not openly licensed for redistribution here. Read it at the source:
Provenance
- Source
- OpenAlex
- DOI
- 10.1111/acel.14002
- Canonical
- link ↗
- Fetched
- 2026-11-04 MST
Cite this
APA
Lin, J.M., Guo, W., Luo, Q., Zhang, Q., Wan, T., Jiang, C., Ye, Y., Lin, H., & Fan, G. (2023). Senolytics prevent caveolar CaV3 . 2‐RyR axis malfunction in old vascular smooth muscle. <em>Aging Cell</em>. https://doi.org/10.1111/acel.14002
Vancouver
Lin JM, Guo W, Luo Q, Zhang Q, Wan T, Jiang C, et al. Senolytics prevent caveolar CaV3 . 2‐RyR axis malfunction in old vascular smooth muscle. Aging Cell. 2023. doi:10.1111/acel.14002.
BibTeX
@article{jie2023Senoly,
title = {Senolytics prevent caveolar CaV3 . 2‐RyR axis malfunction in old vascular smooth muscle},
author = {Jie Ming Lin and Weiming Guo and Qingtian Luo and Qingping Zhang and Teng Wan and Changyu Jiang and Yuanchun Ye and Haihuan Lin and Gang Fan},
journal = {Aging Cell},
year = {2023},
doi = {10.1111/acel.14002},
}
Research neighborhood
References, citing works, and semantically nearest findings. Click a node to open it.
Related findings
2023
Open access · CC-BY
Analysis of Somatic Mutations in Senescent Cells Using Single-Cell Whole-Genome Sequencing
Aging cell 2026
Citation only
Chronic Senolytic Treatment and/or Aerobic Exercise Reduce Senescence and Improve Myocardial Function During Aging in the Heart.
Aging Cell 2026
Open access · CC-BY
Chronic Senolytic Treatment and/or Aerobic Exercise Reduce Senescence and Improve Myocardial Function During Aging in the Heart
International Journal of Molecular Sciences 2021
Open access · CC-BY
Dynamic Crosstalk between Vascular Smooth Muscle Cells and the Aged Extracellular Matrix
GeroScience 2026
Open access · CC-BY
Brain senescence drives sarcopenia-like transcriptomic remodeling in skeletal muscle
Nature Communications 2020
Open access · CC-BY